FDA 510(k)

ASCENSIA DEX 2 DIABETES CARE SYSTEM

K-Number: K023584 · 2002-11-20

Decision Date2002-11-20

Product CodeNBW

Advisory CommitteeCH

DecisionSubstantially Equivalent

Device Summary

ASCENSIA DEX 2 DIABETES CARE SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Bayer Corp.. It received FDA 510(k) clearance on 2002-11-20 under 510(k) number K023584. The device is classified under product code NBW. It was reviewed by the CH advisory panel. Product code NBW falls under the category of OB/GYN, which includes obstetric and gynecological diagnostic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ASCENSIA DEX 2 DIABETES CARE SYSTEM?

ASCENSIA DEX 2 DIABETES CARE SYSTEM is a medical device that received FDA 510(k) clearance on 2002-11-20. The listed applicant is Bayer Corp.. The 510(k) number is K023584.

When did ASCENSIA DEX 2 DIABETES CARE SYSTEM receive FDA 510(k) clearance?

ASCENSIA DEX 2 DIABETES CARE SYSTEM received FDA 510(k) clearance on 2002-11-20, under 510(k) number K023584.

Who is the listed applicant for ASCENSIA DEX 2 DIABETES CARE SYSTEM?

The FDA 510(k) record lists Bayer Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ASCENSIA DEX 2 DIABETES CARE SYSTEM?

The FDA product code for ASCENSIA DEX 2 DIABETES CARE SYSTEM is NBW. This falls under the OB/GYN category.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Bayer Corp. as applicant

K024062ASCENSIA BREEZE BLOOD GLUCOSE METER K023944BAYER DIAGNOSTICS CLINITEST PREGNANCY TEST K024017BAYER ADVIA CENTAUR HER-2/NEU ASSAY K024234ASCENSIA GLUCOFACTS; ASCENSIA GLUCOFACTS PROFESSIONAL K022288COMPLEXED PROSTATE SPECIFIC ANTIGEN (CPSA) ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM K020828CA 125 ASSAY FOR THE ADVIA CENTAUR SYSTEM

View all 96 devices →

Related Devices (Code: NBW)

K260545CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System; CONTOUR® NEXT ONE Blood Glucose Monitoring SystemAscensia Diabetes Care K262116TRUE METRIX Self Monitoring Blood Glucose SystemTrividia Health, Inc.K250085On Call® Sure GK Blood Glucose & Ketone Monitoring System; On Call® Sure Sync GK Blood Glucose & Ketone Monitoring SystemACON Laboratories, Inc.K243060TeleRPM Gen2 Blood Glucose Monitoring SystemGuangdong Transtek Medical Electronics Co., Ltd.K240637RIGHTEST Blood Glucose Monitoring System Max TelBionime Corporation K240640Sejoy Blood Glucose Monitoring System; Sejoy Advance Link Blood Glucose Monitoring SystemSejoy Biomedical Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.